These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Molendijk ML; Bus BA; Spinhoven P; Penninx BW; Kenis G; Prickaerts J; Voshaar RC; Elzinga BM Mol Psychiatry; 2011 Nov; 16(11):1088-95. PubMed ID: 20856249 [TBL] [Abstract][Full Text] [Related]
3. Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine. Munno D; Sterpone S; Fania S; Cappellin F; Mengozzi G; Saroldi M; Bechon E; Zullo G Panminerva Med; 2013 Dec; 55(4):377-84. PubMed ID: 24434345 [TBL] [Abstract][Full Text] [Related]
4. Critical role of brain-derived neurotrophic factor in mood disorders. Hashimoto K; Shimizu E; Iyo M Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621 [TBL] [Abstract][Full Text] [Related]
5. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients. Yoshimura R; Kishi T; Suzuki A; Umene-Nakano W; Ikenouchi-Sugita A; Hori H; Otani K; Iwata N; Nakamura J Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1022-5. PubMed ID: 21338649 [TBL] [Abstract][Full Text] [Related]
6. Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder. Ramesh V; Venkatesan V; Chellathai D; Silamban S Neuropsychobiology; 2021; 80(3):201-213. PubMed ID: 32731218 [TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters. Skibinska M; Kapelski P; Rajewska-Rager A; Pawlak J; Szczepankiewicz A; Narozna B; Twarowska-Hauser J; Dmitrzak-Weglarz M Nord J Psychiatry; 2018 Apr; 72(3):191-196. PubMed ID: 29235396 [TBL] [Abstract][Full Text] [Related]
8. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Yoshimura R; Mitoma M; Sugita A; Hori H; Okamoto T; Umene W; Ueda N; Nakamura J Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1034-7. PubMed ID: 17459550 [TBL] [Abstract][Full Text] [Related]
10. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression. Serra-Millàs M; López-Vílchez I; Navarro V; Galán AM; Escolar G; Penadés R; Catalán R; Fañanás L; Arias B; Gastó C Psychopharmacology (Berl); 2011 Jul; 216(1):1-8. PubMed ID: 21308467 [TBL] [Abstract][Full Text] [Related]
11. Interaction between BDNF and serotonin: role in mood disorders. Martinowich K; Lu B Neuropsychopharmacology; 2008 Jan; 33(1):73-83. PubMed ID: 17882234 [TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Hashimoto K Psychiatry Clin Neurosci; 2010 Aug; 64(4):341-57. PubMed ID: 20653908 [TBL] [Abstract][Full Text] [Related]
13. BDNF in late-life depression: effect of SSRI usage and interaction with childhood abuse. van der Meij A; Comijs HC; Dols A; Janzing JG; Oude Voshaar RC Psychoneuroendocrinology; 2014 May; 43():81-9. PubMed ID: 24703173 [TBL] [Abstract][Full Text] [Related]
14. A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment. Sagud M; Nikolac Perkovic M; Vuksan-Cusa B; Maravic A; Svob Strac D; Mihaljevic Peles A; Zivkovic M; Kusevic Z; Pivac N Psychopharmacology (Berl); 2016 Sep; 233(17):3259-67. PubMed ID: 27356518 [TBL] [Abstract][Full Text] [Related]
15. Neuronal plasticity: a link between stress and mood disorders. Calabrese F; Molteni R; Racagni G; Riva MA Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S208-16. PubMed ID: 19541429 [TBL] [Abstract][Full Text] [Related]
16. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. Masi G; Brovedani P CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117 [TBL] [Abstract][Full Text] [Related]
17. Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia. Liu X; Zhang J; Sun D; Fan Y; Zhou H; Fu B Clin Interv Aging; 2014; 9():411-8. PubMed ID: 24648723 [TBL] [Abstract][Full Text] [Related]
18. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Teixeira AL; Barbosa IG; Diniz BS; Kummer A Biomark Med; 2010 Dec; 4(6):871-87. PubMed ID: 21133708 [TBL] [Abstract][Full Text] [Related]
19. Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. Başterzi AD; Yazici K; Aslan E; Delialioğlu N; Taşdelen B; Tot Acar S; Yazici A Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):281-5. PubMed ID: 19110026 [TBL] [Abstract][Full Text] [Related]
20. [Neurotrophic factors and their role in the pathogenesis of affective disorders]. Filuś JF; Rybakowski J Psychiatr Pol; 2005; 39(5):883-97. PubMed ID: 16358589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]